Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Kelsen

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Cancer Investigation|April 1, 1999
A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesotheliomaE M O'Reilly, D H Ilson, L B Saltz, et al.
Cancer Journal (Sudbury, Mass.)|November 18, 2000
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagusD H Ilson, A Forastiere, M Arquette, et al.
Journal of the National Cancer Institute|July 20, 1994
Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagusJ A Ajani, D H Ilson, K Daugherty, et al.
American Journal of Clinical Oncology|October 1, 1983
Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinomaD P Kelsen, R Heelan, C Coonley, et al.
American Journal of Clinical Oncology|December 1, 1996
Phase II study of ZD1694 in patients with advanced gastric cancerN J Meropol, R Pazdur, M Vincent, et al.
Cancer Investigation|January 1, 1995
Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancerB D Minsky, A M Cohen, W E Enker, et al.
Cancer Treatment Reports|July 1, 1978
cis-Dichlorodiammineplatinum(II) and bleomycin in the treatment of esophageal carcinomasD P Kelsen, E Cvitkovic, M Bains, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Flow cytometry as a predictive indicator in patients with operable gastric cancerD M Nanus, D P Kelsen, D Niedzwiecki, et al.
Cancer|August 1, 1993
Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potentialN Altorki, G K Schwartz, M Blundell, et al.
Cancer|May 1, 1995
A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinomaD H Ilson, M Sirott, L Saltz, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Cancer Investigation|April 1, 1999
A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesotheliomaE M O'Reilly, D H Ilson, L B Saltz, et al.
Cancer Journal (Sudbury, Mass.)|November 18, 2000
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagusD H Ilson, A Forastiere, M Arquette, et al.
Journal of the National Cancer Institute|July 20, 1994
Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagusJ A Ajani, D H Ilson, K Daugherty, et al.
American Journal of Clinical Oncology|October 1, 1983
Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinomaD P Kelsen, R Heelan, C Coonley, et al.
American Journal of Clinical Oncology|December 1, 1996
Phase II study of ZD1694 in patients with advanced gastric cancerN J Meropol, R Pazdur, M Vincent, et al.
Cancer Investigation|January 1, 1995
Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancerB D Minsky, A M Cohen, W E Enker, et al.
Cancer Treatment Reports|July 1, 1978
cis-Dichlorodiammineplatinum(II) and bleomycin in the treatment of esophageal carcinomasD P Kelsen, E Cvitkovic, M Bains, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Flow cytometry as a predictive indicator in patients with operable gastric cancerD M Nanus, D P Kelsen, D Niedzwiecki, et al.
Cancer|August 1, 1993
Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potentialN Altorki, G K Schwartz, M Blundell, et al.
Cancer|May 1, 1995
A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinomaD H Ilson, M Sirott, L Saltz, et al.
Pageof 13